Caroline Ram-Wolff
Caroline Ram-Wolff is an expert in Dermatology at Hôpital Saint-Louis (France). As of October 2026, ScienceLeadR ranks Caroline Ram-Wolff in the top 1% of experts worldwide for Lymphoma and Lymphoproliferative Disorders. Caroline Ram-Wolff has authored 272 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 2 of them ongoing. SLR score: 695 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Oncology - Hematology - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2010 - 2026
Number : 272
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Durable remission after allogeneic transplantation despite residual blood disease in Sézary syndrome. PMID 42615645 — sexually transmitted diseases, blood, sezary syndrome, transplantation, homologous, skin diseases, hematologic diseases, transplantation | J Eur Acad Dermatol Venereol | 2026 | 0 |
| Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome. PMID 42490360 — syphilis, sezary syndrome, dermatology | Br J Dermatol | 2026 | 0 |
| Cutaneous T-cell lymphoma in the setting of NIPAL4-related nonsyndromic epidermal differentiation disorder: three cases. PMID 42482319 — cells, syphilis, lymphoma, lymphoma, t-cell, cutaneous, t-lymphocytes, dermatology, lymphoma, t-cell | Br J Dermatol | 2026 | 0 |
| Efficacy of anifrolumab in one patient with concomitant systemic lupus erythematosus and subcutaneous panniculitis-like T-cell lymphoma. PMID 42061930 — cells, sexually transmitted diseases, lymphoma, lupus erythematosus, systemic, t-lymphocytes, panniculitis, dermatology, lymphoma, t-cell | Ann Dermatol Venereol | 2026 | 0 |
| Clinical characteristics of mycosis fungoides with angiotropism. PMID 40801107 — sexually transmitted diseases, mycosis fungoides, skin diseases, prognosis | J Eur Acad Dermatol Venereol | 2025 | 0 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Phase 2 Study of PTX 100 Monotherapy in Patients with r r CTCL 2025-521852-45-00 — cells, safety, lymphoma, lymphoma, t-cell, cutaneous, t-lymphocytes, pharmacokinetics, lymphoma, t-cell | Phase 2 | Recruiting | 2026 |
| A Phase 1 Multicenter Open label Prospective First in human Dose escalation Clinical Trial of Domain Therapeutics Anti CCR8 Monoclonal Antibody (DT 7012) in Patients With Relapsed or Refractory Cutaneous T cell Lymphomas (CTCL) NCT07213882 — clinical trials, phase i as topic, skin, cells, mycosis fungoides, safety, sezary syndrome, lymphoma, neoplasms, lymphoma, t-cell, cutaneous, antibodies, monoclonal, therapeutics, t-lymphocytes, lymphoma, t-cell | Early Phase 1 | Not yet recruiting | 2026 |
LeadR Networks
Main global connection map